Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.
about
Brain Structural Effects of Psychopharmacological Treatment in Bipolar DisorderNeuroimaging in psychiatric pharmacogenetics research: the promise and pitfallsThe gray matter volume of the amygdala is correlated with the perception of melodic intervals: a voxel-based morphometry study.Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.Interpreting magnetic resonance imaging findings in bipolar disorder.Effects of medication on neuroimaging findings in bipolar disorder: an updated review.Potential mechanisms of action of lithium in bipolar disorder. Current understanding.Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology.Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.Amygdala enlargement in unaffected offspring of bipolar parents.Neurocircuitry of mood disorders.Increased subgenual cingulate cortex volume in pediatric bipolar disorder associated with mood stabilizer exposureNeuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.Identify changes of brain regional homogeneity in bipolar disorder and unipolar depression using resting-state FMRIAlterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging studyPutative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderEffects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder.Habenula volume in post-traumatic stress disorder measured with high-resolution MRI.Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorderFrontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy studyInflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities.Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not treated with lithiumSex differences of gray matter morphology in cortico-limbic-striatal neural system in major depressive disorderClinical application of brain imaging for the diagnosis of mood disorders: the current state of play.Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching.Amygdala volume changes in posttraumatic stress disorder in a large case-controlled veterans group.A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity.Understanding heterogeneity in PTSD: fear, dysphoria, and distress.Neuroimaging in the field of psychoses.Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force.Disorders and borders: psychiatric genetics and nosology.Co-altered functional networks and brain structure in unmedicated patients with bipolar and major depressive disorders.In vivo delineation of subdivisions of the human amygdaloid complex in a high-resolution group template.The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry.Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder.Low left amygdala volume is associated with a longer duration of unipolar depression.Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients.Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.
P2860
Q26786245-0E118CAA-CACD-4028-A950-6E433FE74604Q26853551-98166D8F-72CF-4443-9636-EBFE5F095186Q30363527-178E25BC-8E2F-4FE0-B646-6CD13EB5A5A2Q30572014-A6D275F1-259B-43B4-A915-C982AD5E5004Q34208183-0FD4AEF8-C89B-49B8-858C-167E967C65ABQ34277299-E2AAFE2C-36A7-417D-930E-E7398FF5DADCQ34325612-8C7063BC-CBDF-4B6B-9584-F297B5AEF2EFQ34364063-5987F16A-4996-4B38-8566-CDD630988325Q34538452-FE8F7B9F-0294-4F63-9791-016FEB4BB2B7Q34622602-8F37572F-736C-40B4-BCB8-E945086CFE31Q34660904-06BB7AA8-5DCF-41B6-BFCB-53295E80931BQ34831830-A919A466-E3AE-4613-ACD5-B8BFD5EB96B5Q34979782-76E383CA-BFA7-424D-9154-ECF16C37886BQ35032598-4D7CDC02-32F7-46C5-BC69-F87D0A509E98Q35063703-FF6C4B8B-F722-436C-BF77-4ED26C2F6834Q35147682-2430CA60-AEA1-49DC-BB38-2DC3515DE1F5Q35164406-D8CE4EFC-95DD-4121-817E-8A02286F2E38Q35647362-3C222788-6F5D-4F73-AE5A-793846920EF0Q35813608-63F5D303-19AA-46BC-A8AA-3A62192D2862Q36061749-73C71FFE-D967-4510-ACF7-106D0850886FQ36203441-685AF98E-9B98-406A-A3AC-723AA793F412Q36295874-057D5F92-8386-4B2C-9595-E2CDB8BAA9A1Q36625412-A297C80B-EF0B-4252-A9DA-D80D92501B40Q36675100-6ED8337E-B092-484D-83C7-E4C590E12BCEQ36765170-1F9884B9-1B0E-4FF2-897E-9AE29D3CFDC4Q36788621-DD2C08EB-CF16-43E3-A8B0-8967E506C81FQ36806406-BC905508-79A3-44FD-9F7B-AA379AD72D03Q36824661-11ED9336-E3C9-4F43-B56A-95249B954FC5Q37015341-8213971C-DDE0-4CBA-9978-ED38AFBADD24Q37510343-39F4B2ED-1044-4A89-93DF-00F3A05D550BQ37963866-27E732EE-E1D7-4439-9093-DCBB4FE9A1D3Q38081648-2AD10EB5-90A6-4A66-A8C1-6BC0A37C7B7EQ38153338-B67FB232-73F1-458C-95A7-36729F1A5AF7Q38732918-08C0A51D-457F-4CB8-848D-58AD44E4EA19Q38847444-B81A0F73-27C0-4E82-9FD0-28ABDD03476DQ39649409-26536710-9BC0-4214-BB01-5110CF349561Q40869832-41B52360-4F80-4DD5-8CEF-4F673D2D44DCQ47701936-963DC994-66E4-49F5-84FA-F63BE70801B4Q47802190-62B7DCB0-8171-4785-92A8-4A957244FD67Q48246382-921DA211-34E1-4E96-9B2A-33C5F2A2398B
P2860
Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Amygdala volume in depressed p ...... MRI: the impact of medication.
@ast
Amygdala volume in depressed p ...... MRI: the impact of medication.
@en
type
label
Amygdala volume in depressed p ...... MRI: the impact of medication.
@ast
Amygdala volume in depressed p ...... MRI: the impact of medication.
@en
prefLabel
Amygdala volume in depressed p ...... MRI: the impact of medication.
@ast
Amygdala volume in depressed p ...... MRI: the impact of medication.
@en
P2093
P2860
P50
P1433
P1476
Amygdala volume in depressed p ...... MRI: the impact of medication.
@en
P2093
Carlos Zarate
David A Luckenbaugh
Dennis S Charney
Earle E Bain
Husseini K Manji
Joseph L Price
Rebecca Sills
Wendy Bogers
P2860
P304
P356
10.1016/J.NEUROIMAGE.2009.11.025
P407
P577
2009-11-17T00:00:00Z